schizophrenia |
37 |
early intervention |
29 |
cost-effectiveness |
26 |
depression |
23 |
mental health |
22 |
depressive symptoms |
21 |
early psychosis |
20 |
cognitive impairment |
19 |
dementia |
19 |
epidemiology |
19 |
psychotic disorders |
19 |
duration of untreated psychosis |
18 |
first-episode schizophrenia |
18 |
older adults |
18 |
hong kong |
17 |
peer support |
17 |
first episode |
16 |
negative symptoms |
16 |
assessment |
14 |
adolescents |
13 |
collaborative stepped care |
13 |
effectiveness |
13 |
elderly |
13 |
executive function |
13 |
functioning |
13 |
insight |
13 |
prevention |
13 |
psychosis |
13 |
stress |
13 |
symptomatology |
13 |
validation study |
13 |
evaluation |
12 |
adolescent |
11 |
first-episode psychosis |
11 |
pattern glare |
11 |
perceptual distortions |
11 |
self-reference |
11 |
youth |
11 |
community-based intervention |
10 |
double blind |
10 |
health economics |
10 |
health service research |
10 |
maintenance |
10 |
medical sciences |
10 |
psychiatry and neurology |
10 |
public health |
10 |
randomized controlled trial |
10 |
relapse prevention |
10 |
stigma |
10 |
youth mental health |
10 |
youth-friendly |
10 |
early medical intervention - methods - trends |
9 |
health education - methods |
9 |
ideas of reference |
9 |
life events |
9 |
mental health services - trends |
9 |
old age psychiatry |
9 |
program development |
9 |
psychotic disorders - therapy |
9 |
psychotic-like experiences |
9 |
rumination |
9 |
traumatic events |
9 |
treatment outcome |
9 |
cognition disorders - etiology |
8 |
cognitive function |
8 |
covid-19 |
8 |
delusions |
8 |
delusions - diagnosis |
8 |
delusions - etiology |
8 |
drug regulatory |
8 |
employment |
8 |
eye-gaze perception |
8 |
frailty |
8 |
health equity |
8 |
help-seeking |
8 |
interview, psychological - methods |
8 |
long-term outcome |
8 |
mass screening - methods |
8 |
mentalization |
8 |
mode of onset |
8 |
nursing home |
8 |
orphan drug policy |
8 |
outcome |
8 |
prospective study |
8 |
psychiatric status rating scales |
8 |
psychotic disorders - complications |
8 |
quality of life |
8 |
rare diseases |
8 |
remission |
8 |
risk factors |
8 |
schizophrenia - complications |
8 |
schizophrenic psychology |
8 |
treatment access |
8 |
age of onset |
7 |
antipsychotic agents - administration and dosage |
7 |
behavioral symptoms - etiology - psychology - therapy |
7 |
caregiving |
7 |
cognition |
7 |
cognitive functions |
7 |
cognitive structure |
7 |
content-dependent process |
7 |
course |
7 |
dementia and cognitive disorders |
7 |
duration of untreated psychosis (dup) |
7 |
early detection |
7 |
early diagnosis |
7 |
endophenotype |
7 |
executive function - physiology |
7 |
first-episode schizophrenia spectrum disorder |
7 |
gender |
7 |
gender difference |
7 |
genotype |
7 |
health service accessibility |
7 |
longitudinal |
7 |
medication-naïve |
7 |
mental health assessments |
7 |
mental health services |
7 |
mental health services - organization and administration |
7 |
neuropsychological tests |
7 |
nomenclature |
7 |
pathways |
7 |
persistent primary negative symptoms |
7 |
person-centered care |
7 |
predictive value of tests |
7 |
predictors |
7 |
premorbid adjustment |
7 |
prospective follow-up |
7 |
psychotherapy - methods |
7 |
psychotic disorders - diagnosis |
7 |
psychotic disorders - diagnosis - drug therapy - therapy |
7 |
psychotic disorders - diagnosis - psychology |
7 |
rehospitalization |
7 |
relapse |
7 |
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
schizophrenia - diagnosis |
7 |
sex characteristics |
7 |
six elements |
7 |
spontaneously reported symptoms |
7 |
stability |
7 |
stereotyping |
7 |
stigmatization |
7 |
stress/burden |
7 |
suicide, attempted - psychology |
7 |
symptom classification |
7 |
terminology as topic |
7 |
treatment delay |
7 |
triage |
7 |
adult |
6 |
aged |
6 |
aging in place |
6 |
alcoholism |
6 |
anxiety disorder |
6 |
asia |
6 |
blinking |
6 |
bone loss |
6 |
bone mineral testing |
6 |
categorization |
6 |
chronological age |
6 |
coping |
6 |
culture |
6 |
delivery of health care - standards |
6 |
diminished expression |
6 |
dopamine |
6 |
down syndrome |
6 |
early medical intervention - standards |
6 |
everyday cognitive function |
6 |
functional outcome |
6 |
global cognitive function |
6 |
intellectual disability |
6 |
longitudinal follow-up |
6 |
mental health services - standards |
6 |
older chinese |
6 |
osteoporosis |
6 |
physical frailty |
6 |
predictive validity |
6 |
recurrence |
6 |
reliability |
6 |
semantic |
6 |
symptomatic remission |
6 |
validation |
6 |
adverse health outcomes |
5 |
antidepressant |
5 |
case management |
5 |
cognitive aging |
5 |
cognitive decline |
5 |
community mental health services |
5 |
diagnostic specificity |
5 |
ecological momentary assessment |
5 |
hospitalization |
5 |
insomnia |
5 |
lifestyle risk reduction |
5 |
minimum data set |
5 |
neurological examination abnormalities |
5 |
pandemic |
5 |
perceived life expectancy |
5 |
physical decline |
5 |
productive aging |
5 |
psychiatric emergency admission |
5 |
psychotic symptoms |
5 |
public awareness |
5 |
review |
5 |
seasonality |
5 |
sleep |
5 |
time investment |
5 |
trait |
5 |
unemployment |
5 |
youth psychosis |
5 |
apoe4 |
4 |
cognitive functioning |
4 |
cognitive reserve |
4 |
cognitive screening |
4 |
collective efficacy |
4 |
community support |
4 |
core competencies |
4 |
delphi method |
4 |
delphi study |
4 |
dementia care |
4 |
discrimination |
4 |
education and lifestyle |
4 |
functional magnetic resonance imaging |
4 |
gerontology and geriatrics |
4 |
glutamatergic system |
4 |
health care policy |
4 |
health policy |
4 |
integrated care model |
4 |
interprofessional education |
4 |
lifestyle |
4 |
low-income elders |
4 |
low-ses elders |
4 |
magnetic resonance spectroscopy |
4 |
mci |
4 |
neighborhood |
4 |
neurocognitive functioning |
4 |
nursing |
4 |
perceived walkability |
4 |
policy priority |
4 |
prejudice |
4 |
psychological well-being |
4 |
psychometrics |
4 |
risk reduction |
4 |
service users |
4 |
social support |
4 |
social-cognitive model |
4 |
stereotype |
4 |
subjective cognitive complaint |
4 |
support networks |
4 |
team cohesiveness |
4 |
team collaboration |
4 |
active life expectancy |
3 |
alzheimer's disease |
3 |
cantonese |
3 |
care needs |
3 |
charls |
3 |
china |
3 |
cognitive performance |
3 |
cognitive performance scale |
3 |
communication |
3 |
community care |
3 |
confirmatory factor analysis |
3 |
cost of care |
3 |
crosswalk |
3 |
educational level |
3 |
episodic memory |
3 |
family care |
3 |
filial piety |
3 |
hayling |
3 |
health expectancies |
3 |
hong kong chinese |
3 |
item response theory |
3 |
kitwood |
3 |
malignant social psychology |
3 |
measurement precision |
3 |
moca 5-min |
3 |
montreal cognitive assessment |
3 |
mood |
3 |
needs assessment |
3 |
nursing home care |
3 |
older people |
3 |
participatory art |
3 |
physician-patient relations |
3 |
positive person work |
3 |
principal component analysis |
3 |
psychological wellbeing |
3 |
questionnaires |
3 |
scale development |
3 |
service providers |
3 |
spoken discourse |
3 |
sullivan's method |
3 |
test equating |
3 |
verbal short term memory |
3 |
affordability |
2 |
attention |
2 |
carer role strain |
2 |
caudate |
2 |
chinese |
2 |
cognitive stimulation therapy (cst) |
2 |
community-based model |
2 |
cst |
2 |
cultural competence |
2 |
cultural competency |
2 |
dementia knowledge |
2 |
depression & mood disorders |
2 |
dmn |
2 |
formative research |
2 |
grey matter morphology |
2 |
intervention modification |
2 |
mild cognitive impairment |
2 |
mindfulness-based cognitive therapy |
2 |
mindfulness-based stress reduction |
2 |
neuropsychiatry |
2 |
nonpharmacological intervention |
2 |
nursing homes |
2 |
psychopathology |
2 |
psychotherapy adaptation and modification framework |
2 |
public health interventions |
2 |
qualitative research |
2 |
resilience |
2 |
resting-state fmri |
2 |
sars |
2 |
schizophrenia & psychotic disorders |
2 |
schizophrenia - diagnosis. |
2 |
self-criticism |
2 |
service accessibility |
2 |
shared care |
2 |
six arts |
2 |
undergraduate students |
2 |
voxel-based morphometry |
2 |
wellbeing |
2 |
aging |
1 |
cognitive defect |
1 |
cost-benefit |
1 |
cost‐benefit |
1 |
cost‐effectiveness |
1 |
cost‐utility |
1 |
cross-cultural |
1 |
disease-modifying medication |
1 |
economic evaluation |
1 |
generativity |
1 |
harmony |
1 |
health technology assessment |
1 |
healthy aging |
1 |
implementation challenges |
1 |
interventions |
1 |
lived experience |
1 |
mental health economics |
1 |
moderate to severe dementia |
1 |
path analysis |
1 |
personal relationships |
1 |
psychosocial intervention |
1 |
research funding |
1 |
return on investment |
1 |
social anxiety |
1 |
societal costs |
1 |
systematic review |
1 |